We are live on ! Find out more
AAF

Andra AP-fonden Portfolio holdings

AUM $8.39B
1-Year Est. Return 21.19%
This Fund
S&P 500
This Quarter Est. Return
+5.81%
1 Year Est. Return
+21.19%
3 Year Est. Return
+70.53%
5 Year Est. Return
10 Year Est. Return
AUM
$3.84B
AUM Growth
+$545M
Cap. Flow
+$415M
Cap. Flow %
10.8%
Top 10 Hldgs %
5.32%
Holding
585
New
18
Increased
351
Reduced
186
Closed
27

Top Sells

Rank Stock Value
1
WU icon
Western Union
WU
+$9.15M
2
SBNY
Signature Bank
SBNY
+$5.66M
3
WST icon
West Pharmaceutical
WST
+$5.32M
4
LNC icon
Lincoln National
LNC
+$4.89M
5
CRM icon
Salesforce
CRM
+$4.44M

Sector Composition

Rank Sector Weight
1 Technology 19.67%
2 Healthcare 16.89%
3 Consumer Discretionary 13.52%
4 Financials 13.32%
5 Industrials 12.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WPM icon
101
Wheaton Precious Metals
WPM
$60.9B
$10.4M 0.27%
159,600
+28,200
+21% +$1.23M
LEN icon
102
Lennar Class A
LEN
$21.2B
$10.4M 0.27%
102,060
+38,221
+60% +$3.69M
CARR icon
103
Carrier Global
CARR
$52.8B
$10.4M 0.27%
226,362
+90,362
+66% +$4.04M
BKNG icon
104
Booking.com
BKNG
$161B
$10.3M 0.27%
97,500
+27,500
+39% +$2.68M
HUM icon
105
Humana
HUM
$46.2B
$10.3M 0.27%
21,300
-6,600
-24% -$3.26M
STLD icon
106
Steel Dynamics
STLD
$37.6B
$10.3M 0.27%
91,400
+21,600
+31% +$2.51M
T icon
107
AT&T
T
$163B
$10.3M 0.27%
534,700
+208,800
+64% +$3.99M
NBIX icon
108
Neurocrine Biosciences
NBIX
$16.6B
$10.3M 0.27%
101,400
+8,700
+9% +$905K
ADBE icon
109
Adobe
ADBE
$105B
$10.2M 0.27%
26,500
+1,800
+7% +$640K
CPRT icon
110
Copart
CPRT
$27.5B
$10.1M 0.26%
267,800
+73,400
+38% +$2.5M
HCA icon
111
HCA Healthcare
HCA
$89.5B
$10M 0.26%
38,100
+15,400
+68% +$3.91M
FNV icon
112
Franco-Nevada
FNV
$46B
$10M 0.26%
50,800
+7,300
+17% +$1.02M
TFII icon
113
TFI International
TFII
$11.5B
$10M 0.26%
62,000
+30,900
+99% +$3.6M
DHI icon
114
D.R. Horton
DHI
$42.3B
$9.99M 0.26%
102,300
+26,000
+34% +$2.48M
EXC icon
115
Exelon
EXC
$47B
$9.98M 0.26%
238,200
+17,400
+8% +$725K
BIO icon
116
Bio-Rad Laboratories Class A
BIO
$9.42B
$9.96M 0.26%
20,800
-5,600
-21% -$2.62M
ADP icon
117
Automatic Data Processing
ADP
$108B
$9.91M 0.26%
44,500
-4,600
-9% -$1.04M
HSIC icon
118
Henry Schein
HSIC
$9.82B
$9.87M 0.26%
121,000
+36,600
+43% +$2.98M
AMGN icon
119
Amgen
AMGN
$222B
$9.86M 0.26%
40,800
-6,200
-13% -$1.52M
EG icon
120
Everest Group
EG
$14.4B
$9.85M 0.26%
27,500
+6,600
+32% +$2.37M
EXAS
121
DELISTED
Exact Sciences
EXAS
$9.83M 0.26%
145,000
+74,100
+105% +$4.76M
ELS icon
122
Equity Lifestyle Properties
ELS
$12.6B
$9.81M 0.26%
146,200
-4,700
-3% -$319K
ORCL icon
123
Oracle
ORCL
$423B
$9.81M 0.26%
105,570
+30,570
+41% +$2.68M
SGEN
124
DELISTED
Seagen Inc. Common Stock
SGEN
$9.8M 0.25%
48,400
-16,900
-26% -$2.71M
CI icon
125
Cigna
CI
$74.6B
$9.74M 0.25%
38,100
-8,400
-18% -$2.45M

Similar funds

Andra AP-fonden's Q1 2023 Portfolio in Review

As of Q1 2023, Andra AP-fonden held 585 positions worth $3.84B, up 17% from $3.3B the previous quarter. Its ten largest holdings account for 5.3% of the portfolio.

Andra AP-fonden deployed $415M of net new capital in Q1 2023, opening 18 new positions and adding to 351 existing holdings. Its largest new stake was Snap: 228,700 shares worth $2.56M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was West Pharmaceutical, an estimated $5.32M trimmed.

  • Andra AP-fonden's largest Q1 2023 buy was Snap: 228,700 shares worth $2.56M.
  • Andra AP-fonden added most to Gilead Sciences in Q1 2023, an estimated $7.75M increase.
  • Andra AP-fonden's biggest Q1 2023 reduction was West Pharmaceutical, cutting an estimated $5.32M.
  • Andra AP-fonden fully exited Western Union in Q1 2023, selling an estimated $9.15M.
  • Andra AP-fonden's ten largest holdings make up 5.3% of its $3.84B portfolio in Q1 2023.
  • Andra AP-fonden opened 18 new positions and closed 27 in Q1 2023.
  • Andra AP-fonden's portfolio value rose 17% quarter-over-quarter to $3.84B.

Based on Andra AP-fonden's 13F filing for Q1 2023, filed 12 May 2023.